HIV-1 latency reversal agent boosting is not limited by opioid use.
Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A.
Lilie T, et al. Among authors: jordan h.
JCI Insight. 2024 Nov 22;9(22):e185480. doi: 10.1172/jci.insight.185480.
JCI Insight. 2024.
PMID: 39470739
Free PMC article.